Kbc Group Nv Nektar Therapeutics Transaction History

Kbc Group Nv

$31.5 Billion
Q1 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Feb 15, 2024	BUY	$3.04 - $5.14 $49,348 - $83,437	16,233 New	16,233 $52,000
Q2 2022 Feb 14, 2024	BUY	$3.17 - $6.17 $22,123 - $43,060	6,979 Added 75.42%	16,233 $62,000
Q2 2022 Jul 26, 2022	BUY	$3.17 - $6.17 $22,123 - $43,060	6,979 Added 75.42%	16,233 $62,000
Q1 2022 Feb 14, 2024	BUY	$4.16 - $13.72 $2,837 - $9,357	682 Added 7.96%	9,254 $50,000
Q1 2022 May 06, 2022	BUY	$4.16 - $13.72 $2,837 - $9,357	682 Added 7.96%	9,254 $50,000

Q4 2021 Feb 14, 2024	BUY	$10.83 - $18.41 $92,834 - $157,810	8,572 New	8,572 $116,000
Q4 2021 Feb 03, 2022	BUY	$10.83 - $18.41 $13,689 - $23,270	1,264 Added 17.3%	8,572 $116,000
Q4 2020 Feb 10, 2021	BUY	$15.77 - $19.03 $27,644 - $33,359	1,753 Added 31.56%	7,308 $124,000
Q3 2020 Oct 28, 2020	SELL	$16.59 - $24.79 $1.18 Million - $1.77 Million	-71,251 Reduced 92.77%	5,555 $92,000
Q2 2020 Aug 10, 2020	SELL	$16.86 - $23.44 $4.75 Million - $6.6 Million	-281,729 Reduced 78.58%	76,806 $1.78 Million
Q1 2020 May 04, 2020	SELL	$14.47 - $27.96 $1.53 Million - $2.97 Million	-106,070 Reduced 22.83%	358,535 $6.4 Million
Q4 2019 Feb 11, 2020	BUY	$15.87 - $23.12 $6.73 Million - $9.81 Million	424,345 Added 1054.01%	464,605 $10 Million
Q3 2019 Nov 07, 2019	BUY	$16.91 - $36.27 $676,061 - $1.45 Million	39,980 Added 14278.57%	40,260 $733,000
Q2 2019 Dec 03, 2019	SELL	$31.0 - $36.3 $444,478 - $520,469	-14,338 Reduced 98.08%	280 $10,000
Q2 2019 Jul 30, 2019	BUY	$31.0 - $36.3 $444,478 - $520,469	14,338 Added 5120.71%	14,618 $0
Q1 2019 Dec 03, 2019	SELL	$31.58 - $46.35 $452,794 - $664,566	-14,338 Reduced 98.08%	280 $9,000
Q1 2019 May 10, 2019	BUY	$31.58 - $46.35 $452,794 - $664,566	14,338 Added 5120.71%	14,618 $0
Q4 2018 Dec 03, 2019	SELL	$30.43 - $56.65 $345,836 - $643,827	-11,365 Reduced 97.6%	280 $9,000
Q2 2018 Aug 03, 2018	SELL	$46.25 - $104.45 $604,533 - $1.37 Million	-13,071 Reduced 52.88%	11,645 $0
Q4 2017 Feb 07, 2018	BUY	$23.02 - $60.5 $568,962 - $1.5 Million	24,716	24,716 $0

Others Institutions Holding NKTR

# of Institutions

128

Shares Held

111M

Call Options Held

150K

Put Options Held

Deep Track Capital, LP Greenwich, CT

18.4M
Shares

$21.5 Million
0.57% of portfolio
Vanguard Group Inc Valley Forge, PA

12M
Shares

$14.1 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

7.57M
Shares

$8.86 Million
0.02% of portfolio
Primecap Management CO Pasadena, CA

6.97M
Shares

$8.15 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.88M
Shares

$6.88 Million
0.0% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account